Inducible nitric oxide synthase attenuates chronic colitis in HLA-B27/human β2-microglobulin transgenic rats

European Cytokine Network

Volumn 12, Issue 1, 2001, Pages 111-118

  Blanchard, H S ^a   Dernis Labous, E ^a   Lamarque, D ^a   Tran van Nhieu, J ^a   Szepes, Z ^a   Flejou J F ^a   Wollman, E ^a   Whittle, B J R ^a   Breban, M ^a  

^a Hôpital Cochin ^*  (France)

Author keywords

Cytokines; In vivo animal models; Inflammation; Nitric oxide; Rodent

Indexed keywords

BETA 2 MICROGLOBULIN; CYTOKINE; DEXAMETHASONE; GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 1BETA; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTHRITIS; ARTICLE; CELL PROTECTION; COLITIS; CONTROLLED STUDY; NONHUMAN; PROTEIN EXPRESSION; RAT; SPONDYLOARTHROPATHY; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; BASE SEQUENCE; BETA 2-MICROGLOBULIN; CHRONIC DISEASE; COLITIS; DEXAMETHASONE; DNA PRIMERS; ENZYME INHIBITORS; HLA-B27 ANTIGEN; HUMANS; IMMUNOHISTOCHEMISTRY; LYSINE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

ANIMALIA; RODENTIA;

EID: 0035072791     PISSN: 11485493     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Associations between ankylosing spondylitis, psoriatic arthritis, Reiter's disease, the intestinal arthropathies, and Behçet's syndrome
2. Inflammatory disease in HLA-B27 transgenic rats
3. Transfer of the inflammatory disease of HLA-B 27 transgenic rats by bone marrow engraftment
4. T cells, but not thymic exposure to HLA-B27, are required for the inflammatory disease of HLA-B 27 transgenic rats
5. Effects of murine recombinant IL-10 on the inflammatory disease of rat transgenic for HLA-B27 and human β2-microglobulin
6. Animal models and in vitro models for the study of aetiopathogenesis of spondyloarthropathies
7. Spontaneous intestinal inflammation and nitric oxide metabolism in HLA-B27 transgenic rats of spondylopathies
8. Inducible nitric oxide synthase: What difference does it make?
9. Nitric oxide in autoimmune disease: Cytotoxic or regulatory mediator
10. Glucocorticolds inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
11. Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes
12. 6-(1-iminoethyl)lysine: A selective inhibitor of inducible nitric oxide synthase
13. Identification of a novel HLA-B27 subtype by retriction analysis of a cytotoxic γδ T cell clone
14. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: Effect of endotoxin challenge
15. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker
16. Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat
17. +)-independent nitric oxide synthases
18. Molecular mechanisms and therapeutic strategies related to nitric oxide
19. Perspectives series: Host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity
20. Evidence against a role for inducible nitric oxide synthase in the hyperdynamic circulation of portal-hypertensive rats
21. Expression of nitric oxide synthase in inflammatory bowel disease is not affected by corticosteroid treatment
22. Dexamethasone suppresses iNOS gene expression by upregulating I-kappa B alpha and inhibiting NF-kappaB
23. Effect of dexamethasone on interleukin-1beta-(IL-1beta)-induced nuclear factor-kappaB (NF-kappaB) and kappaB-dependent transcription in epithelial cells
24. Cytokine induction of NO synthase II in human DLD-1 cells: Roles of the JAK-STAT, AP-1 and NF-kappaB-signaling pathways
25. The role of nitric oxide in inflammation and immunity
26. Endogenously produced nitric oxide increases tumor necrosis factor-alpha production in transfected human U 937 cells
27. Nitric oxide downregulates tumour necrosis factor mRNA in RAW 264.7 cells
28. Effects of nitric oxide synthase inhibition or sulfasalazine on the spontaneous colitis observed in HLA-B 27 transgenic rats
29. Nitric oxyde synthase activity in ulcerative colitis and Crohn's disease
30. A proinflammatory activity of interleukin-8 in human skin: Expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes
31. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: Modulation by T lymphocyte derived cytokines
32. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation
33. Peroxynitrite-induced rat colitis: A new model of colonic inflammation
34. Cytokine production in patients with inflammatory bowel disease
35. Enhanced secretion of tumour necrosis factor-α, IL-6, and IL-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease
36. Molecular evidence for two forms of Crohn disease
37. Nitric oxide and inflammatory bowel diseases